NRC Health (NRC) stock analysis

P/E against its history

Not enough price and earnings history to compare.

P/E against the industry

Needs positive earnings and enough profitable companies in the industry.

EV/EBITDA above its 5-year median

NRC Health's EV/EBITDA of 28.4 is above its 5-year median of 18.4.

P/S above the industry

NRC Health's price-to-sales of 4.13 is above the Engineering, Accounting, Research, Management, and Related Services median of 3.97 (book value is negative, so we use sales).

Trading above fair value

The share price of $26.86 is above our fair value estimate of $14.71.

Margin of safety under 20%

The price is 82.6% above fair value, so there is no margin of safety.

Revenue growing under 10% a year

Revenue grew -3.2% a year over the last three fiscal years, short of the 10% we look for.

EPS growing 10%+ a year

Diluted EPS grew 240% a year over the last three fiscal years.

Earnings acceleration

Needs positive net income now, a year ago and five years ago.

Growing slower than the industry

Revenue grew 3.4% over the last twelve months; the Engineering, Accounting, Research, Management, and Related Services median is 6.6%.

Company guidance

No outlook found in earnings releases from the last twelve months.

Gross margin trend

This company does not report gross profit.

Return on equity

Needs positive equity and five years of results.

Return on capital over 10%

Return on invested capital was 10.9%, above the 10% that usually covers the cost of capital.

Return on equity against the industry

Needs positive equity.

Earnings over 5 years

Needs positive net income five years ago and in the latest year.

Net margin against its history

Needs five years of revenue and net income.

Net margin against the industry

Needs revenue and net income.

Debt level

Needs debt and equity figures.

Debt trend

Needs a balance sheet from five years ago with positive equity.

Debt covered by cash flow

Operating cash flow over the last twelve months equals 23.1% of total debt.

Interest not well covered

Operating income covers interest expense 2.9 times; we look for at least 5.

Short-term assets don't cover short-term debts

Current assets are 0.64 times current liabilities.

Low bankruptcy risk

The Altman Z-score is 3.45; above 3 is the safe zone and below 1.8 the distress zone.

Pays a dividend

NRC Health paid dividends worth 2.4% of the share price over the last twelve months.

Yield below Treasuries

The 2.4% yield is below the 4.4% on a 1-year Treasury.

Yield below the top quarter

The top quarter of US dividend payers yield 3.8% or more; NRC Health yields 2.4%.

Dividend was cut

The dividend per share fell by more than 10% at least once in the last 7 fiscal years.

Earnings cover

Needs dividends paid and net income.

Covered by free cash flow

Dividends take 73.0% of free cash flow.